TrovaGene
Why Robinhood?
You can watch TrovaGene and buy or sell other stocks, ETFs, and their options commission-free!About TROV
Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The firm is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics.
TROV Key Statistics
Stock Snapshot
TrovaGene(TROV) stock is priced at $1.19, giving the company a market capitalization of 81.28M. It carries a P/E multiple of -2.36.
TrovaGene(TROV) stock opened on 2026-04-01 at —. The price climbed to — and dipped to —.
The TrovaGene(TROV)'s current trading volume is 0, compared to an average daily volume of 559.25K.
During the past year, TrovaGene(TROV) stock moved between $1.48 at its lowest and $4.56 at its peak.
During the past year, TrovaGene(TROV) stock moved between $1.48 at its lowest and $4.56 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.